Risk of postprandial insulin resistance: The liver/vagus rapport

Reviews in Endocrine and Metabolic Disorders

Volumn 15, Issue 1, 2014, Pages 67-77

  Macedo, Maria Paula ^a,b   Lima, Inês S ^a,c   Gaspar, Joana M ^a,c   Afonso, Ricardo A ^a   Patarrão, Rita S ^a   Kim, Young Bum ^c   Ribeiro, Rogério T ^a,b  

^a NOVA MEDICAL SCHOOL   (Portugal)

^b Portuguese Diabetes Association Education and Research Center (APDP ERC)   (Portugal)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Glucose intolerance; Glutathione; Liver; Nitric oxide; Postprandial insulin resistance; Vagus

Indexed keywords

ARTICLE; FEEDING BEHAVIOR; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HUMAN; INGESTION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE; LIVER; MEAL; METABOLIC REGULATION; NONHUMAN; NUTRIENT; PARASYMPATHETIC FUNCTION; PARASYMPATHETIC NERVE; PATHOPHYSIOLOGY; POSTPRANDIAL STATE; RISK ASSESSMENT; VAGUS NERVE;

ANIMALS; BLOOD GLUCOSE; GLUCOSE INTOLERANCE; GLUTATHIONE; HUMANS; INSULIN RESISTANCE; LIVER; POSTPRANDIAL PERIOD; VAGUS NERVE;

EID: 84896315769     PISSN: 13899155     EISSN: 15732606     Source Type: Journal    
DOI: 10.1007/s11154-013-9281-5     Document Type: Article

References (117)

1. Garber AJ, Handelsman Y, Einhorn D, Bergman DA, Bloomgarden ZT, Fonseca V, et al. Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? a consensus statement from the American College of endocrinology and the American Association of clinical endocrinologists. Endocr Pract. 2008;14(7):933-46.
2. Zhang Y, Dall TM, Chen Y, Baldwin A, Yang W, Mann S, et al. Medical cost associated with prediabetes. Popul Health Manag. 2009;12(3):157-63. doi:10.1089/pop.2009.12302.
3. Soriguer F, Goday A, Bosch-Comas A, Bordiu E, Calle-Pascual A, Carmena R, et al. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es study. Diabetologia. 2012;55(1):88-93. doi:10.1007/s00125- 011-2336-9.
4. Gardete-Correia L, Boavida JM, Raposo JF, Mesquita AC, Fona C, Carvalho R, et al. First diabetes prevalence study in Portugal: PREVADIAB study. Diabet Med. 2010;27(8):879 - 81. doi:10.1111/j.1464-5491.2010.03017.x.
5. Ceriello A. Does postprandial blood glucose matter and why? Endocrinol Nutr. 2009;56(S4):8-11. doi:10.1016/S1575-0922(09)73508-9.
6. Ceriello A. Point: postprandial glucose levels are a clinically important treatment target. Diabetes Care. 2010;33(8):1905-7. doi:10.2337/dc10-0634.
7. Kalsbeek A, Bruinstroop E, Yi CX, Klieverik LP, La Fleur SE, Fliers E. Hypothalamic control of energy metabolism via the autonomic nervous system. Ann N Y Acad Sci. 2010;1212:114-29. doi:10.1111/j.1749-6632.2010.05800.x.
8. Greenfield JR, Campbell LV. Role of the autonomic nervous system and neuropeptides in the development of obesity in humans: targets for therapy? Curr Pharm Des. 2008;14(18):1815-20. (Pubitemid 351998585)
9. Lautt WW. Hepatic parasympathetic neuropathy as cause of maturity-onset diabetes? Gen Pharmacol. 1980;11(4):343-5. (Pubitemid 10076541)
10. Takayama S, Sakura H, Katsumori K, Wasada T, Iwamoto Y. A possible involvement of parasympathetic neuropathy on insulin resistance in patients with type 2 diabetes. Diabetes Care. 2001;24(5):968-9. (Pubitemid 33636085)
11. Teff KL. Visceral nerves: vagal and sympathetic innervation. JPEN J Parenter Enteral Nutr. 2008;32(5):569 - 71. doi:10.1177/0148607108321705.
12. Ribeiro RT, Lautt WW, Legare DJ, Macedo MP. Insulin resistance induced by sucrose feeding in rats is due to an impairment of the hepatic parasympathetic nerves. Diabetologia. 2005;48(5):976-83. doi:10.1007/s00125-005-1714-6. (Pubitemid 40767992)
13. Selz R, Theintz G, Tappy L, Schneiter P. Evaluation of hepatic and whole body glycogen metabolism in humans during repeated administrations of small loads of 13C glucose. Diabetes Metab. 2003;29(6):643-9. (Pubitemid 38082168)
14. Lee J, Cummings BP, Martin E, Sharp JW, Graham JL, Stanhope KL, et al. Glucose sensing by gut endocrine cells and activation of the vagal afferent pathway is impaired in a rodent model of type 2 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol. 2012;302(6):R657-66. doi:10.1152/ajpregu.00345.2011.
15. Ahren B, Larsson H. Impaired glucose tolerance (IGT) is associated with reduced insulin-induced suppression of glucagon concentrations. Diabetologia. 2001;44(11):1998-2003. doi:10.1007/s001250100003. (Pubitemid 33124044)
16. Lee KC, Miller RE. The hepatic vagus nerve and the neural regulation of insulin secretion. Endocrinology. 1985;117(1):307-14. (Pubitemid 15019820)
17. Uyama N, Geerts A, Reynaert H. Neural connections between the hypothalamus and the liver. Anat Rec A: Discov Mol Cell Evol Biol. 2004;280(1):808-20. doi:10.1002/ar.a.20086. (Pubitemid 39330960)
18. Berthoud HR. Anatomy and function of sensory hepatic nerves. Anat Rec A: Discov Mol Cell Evol Biol. 2004;280(1):827-35. doi: 10.1002/ar.a.20088.
19. Berthoud HR. The vagus nerve, food intake and obesity. Regul Pept. 2008;149(1-3):15-25. doi:10.1016/j.regpep.2007.08.024.
20. Shimazu T, Matsushita H, Ishikawa K. Cholinergic stimulation of the rat hypothalamus: effects of liver glycogen synthesis. Science. 1976;194(4264):535- 6.
21. Knight CM, Gutierrez-Juarez R, Lam TK, Arrieta-Cruz I, Huang L, Schwartz G, et al. Mediobasal hypothalamic SIRT1 is essential for resveratrol's effects on insulin action in rats. Diabetes. 2011;60(11): 2691-700. doi:10.2337/db10- 0987.
22. Zhang Q, Yu J, Liu B, Lv Z, Xia T, Xiao F, et al. Central activating transcription factor 4 (ATF4) regulates hepatic insulin resistance in Mice via S6K1 Signaling and the Vagus Nerve. Diabetes. 2013;62(7):2230-9. doi:10.2337/db12-1050.
23. Fernandes AB, Patarrao RS, Videira PA, Macedo MP. Understanding postprandial glucose clearance by peripheral organs: the role of the hepatic parasympathetic system. J Neuroendocrinol. 2011;23(12):1288- 95. doi:10.1111/j.1365-2826.2011.02226.x.
24. Balks HJ, Jungermann K. Regulation of peripheral insulin/glucagon levels by rat liver. Eur J Biochem. 1984;141(3):645-50. (Pubitemid 14082363)
25. Lautt WW. The HISS story overview: a novel hepatic neurohumoral regulation of peripheral insulin sensitivity in health and diabetes. Can J Physiol Pharmacol. 1999;77(8):553-62.
26. Xie H, Lautt WW. Induction of insulin resistance by cholinergic blockade with atropine in the cat. J Auton Pharmacol. 1995;15(5): 361-9.
27. Takayama S, Legare DJ, Lautt WW. Dose-related atropine-induced insulin resistance: comparing intraportal versus intravenous administration. Proc West Pharmacol Soc. 2000;43:33-4.
28. Xie H, Lautt WW. Insulin resistance caused by hepatic cholinergic interruption and reversed by acetylcholine administration. Am J Physiol. 1996;271(3 Pt 1):E587-92.
29. Lautt WW, Macedo MP, Sadri P, Takayama S, Duarte Ramos F, Legare DJ. Hepatic parasympathetic (HISS) control of insulin sensitivity determined by feeding and fasting. Am J Physiol Gastrointest Liver Physiol. 2001;281(1):G29-36.
30. DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin North Am. 2004;88(4):787-835. doi:10.1016/j.mcna.2004.04.013. ix. (Pubitemid 39090340)
31. Zhang L, Keung W, Samokhvalov V, Wang W, Lopaschuk GD. Role of fatty acid uptake and fatty acid beta-oxidation in mediating insulin resistance in heart and skeletal muscle. Biochim Biophys Acta. 2010;1801(1):1-22. doi:10.1016/j.bbalip.2009.09.014.
32. Abdul-Ghani MA, DeFronzo RA. Pathogenesis of insulin resistance in skeletal muscle. J Biomed Biotechnol. 2010;2010:476279. doi: 10.1155/2010/476279.
33. Delarue J, Magnan C. Free fatty acids and insulin resistance. Curr Opin Clin Nutr Metab Care. 2007;10(2):142-8. doi:10.1097/MCO.0b013e328042ba90. (Pubitemid 46220305)
34. Feuvray D, Darmellah A. Diabetes-related metabolic perturbations in cardiacmyocyte. Diabetes Metab. 2008;34 Suppl 1:S3-9. doi:10. 1016/S1262-3636(08)70096-X.
35. Heather LC, Clarke K. Metabolism, hypoxia and the diabetic heart. J Mol Cell Cardiol. 2011;50(4):598- 605. doi:10.1016/j.yjmcc.2011.01.007.
36. Abel ED. Glucose transport in the heart. Front Biosci. 2004;9:201-15.
37. An D, Rodrigues B. Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol. 2006;291(4):H1489-506. doi:10.1152/ajpheart.00278.2006. (Pubitemid 44497651)
38. Gerich JE. Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications. Diabet Med. 2010;27(2):136-42. doi:10.1111/j.1464-5491.2009.02894.x.
39. Xie H, Lautt WW. M1 muscarinic receptor blockade causes insulin resistance in the cat. Proc West Pharmacol Soc. 1995;38:83-4.
40. Sadri P, Lautt WW. Blockade of hepatic nitric oxide synthase causes insulin resistance. Am J Physiol. 1999;277(1 Pt 1):G101-8. (Pubitemid 29352650)
41. Guarino MP, Correia NC, Lautt WW, Macedo MP. Insulin sensitivity is mediated by the activation of the ACh/NO/cGMP pathway in rat liver. Am J Physiol Gastrointest Liver Physiol. 2004;287(3):G527-32. doi:10.1152/ajpgi.00085.2004. (Pubitemid 39096617)
42. Guarino MP, Afonso RA, Raimundo N, Raposo JF, Macedo MP. Hepatic glutathione and nitric oxide are critical for hepatic insulin-sensitizing substance action. Am J Physiol Gastrointest Liver Physiol. 2003;284(4):G588-94. doi:10.1152/ajpgi.00423.2002. (Pubitemid 36343208)
43. Lu SC. Regulation of glutathione synthesis. Mol Aspects Med. 2009;30(1-2):42-59. doi:10.1016/j.mam.2008.05.005.
44. Yuan L, Kaplowitz N. Glutathione in liver diseases and hepatotoxicity. Mol Aspects Med. 2009;30(1-2):29-41. doi:10. 1016/j.mam.2008.08.003.
45. Hogg N. The biochemistry and physiology of S-nitrosothiols. Annu Rev Pharmacol Toxicol. 2002;42:585-600. doi:10.1146/annurev.pharmtox.42.092501. 104328. (Pubitemid 34160536)
46. Khamaisi M, Kavel O, Rosenstock M, Porat M, Yuli M, Kaiser N, et al. Effect of inhibition of glutathione synthesis on insulin action: in vivo and in vitro studies using buthionine sulfoximine. Biochem J. 2000;349(Pt 2):579-86. (Pubitemid 30465793)
47. De Mattia G, Bravi MC, Laurenti O, Cassone-Faldetta M, Armiento A, Ferri C, et al. Influence of reduced glutathione infusion on glucose metabolismin patients with non-insulin-dependent diabetes mellitus. Metabolism. 1998;47(8):993-7. (Pubitemid 28364620)
48. Guarino MP, Macedo MP. Co-administration of glutathione and nitric oxide enhances insulin sensitivity in Wistar rats. Br J Pharmacol. 2006;147(8):959-65. doi:10.1038/sj.bjp.0706691.
49. Fernandes AB, Guarino MP, Macedo MP. Understanding the in-vivo relevance of S-nitrosothiols in insulin action. Can J Physiol Pharmacol. 2012;90(7):887-94. doi:10.1139/y2012-090.
50. Santos C, Afonso RA, Guarino MP, Patarrao RS, Fernandes A, Noronha JP, et al. In vitro nitrosation of insulin A- and B-chains. Eur J Mass Spectrom (Chichester, Eng). 2006;12(5):331-8. doi:10.1255/ejms.835.
51. Ramachandran N, Root P, Jiang XM, Hogg PJ, Mutus B. Mechanism of transfer of NO from extracellular S-nitrosothiols into the cytosol by cell-surface protein disulfide isomerase. Proc Natl Acad Sci U S A. 2001;98(17):9539-44. doi:10.1073/pnas.171180998. (Pubitemid 32769339)
52. Lu SC, Garcia-Ruiz C, Kuhlenkamp J, Ookhtens M, Salas-Prato M, Kaplowitz N. Hormonal regulation of glutathione efflux. J Biol Chem. 1990;265(27):16088- 95.
53. Lu SC, Kuhlenkamp J, Garcia-Ruiz C, Kaplowitz N. Hormone-mediated down-regulation of hepatic glutathione synthesis in the rat. J Clin Invest. 1991;88(1):260-9. doi:10.1172/JCI115286.
54. Patarrao RS, Lautt W, Schafer J, Macedo M. Glucagon causes HISS-dependent insulin resistance. Diabetologia. 2007;50:S233.
55. Tsochatzis EA, Manolakopoulos S, Papatheodoridis GV, Archimandritis AJ. Insulin resistance and metabolic syndrome in chronic liver diseases: old entities with new implications. Scand J Gastroenterol. 2009;44(1):6-14. doi:10.1080/00365520802273058.
56. Haffner SM. Relationship of metabolic risk factors and development of cardiovascular disease and diabetes. Obesity (Silver Spring). 2006;14 Suppl 3:121S-7S. doi:10.1038/oby.2006.291.
57. Selberg O, Burchert W, van den Hoff J, Meyer GJ, Hundeshagen H, Radoch E, et al. Insulin resistance in liver cirrhosis. Positronemission tomography scan analysis of skeletal muscle glucose metabolism. J Clin Invest. 1993;91(5):1897-902. doi:10.1172/JCI116407. (Pubitemid 23141457)
58. Lautt WW, Ming Z, Macedo MP, Legare DJ. HISS-dependent insulin resistance (HDIR) in aged rats is associated with adiposity, progresses to syndrome X, and is attenuated by a unique antioxidant cocktail. Exp Gerontol. 2008;43(8):790-800. doi:10.1016/j.exger.2008.04.013.
59. Piccirillo G, Bucca C, Bauco C, Cinti AM, Michele D, Fimognari FL, et al. Power spectral analysis of heart rate in subjects over a hundred years old. Int J Cardiol. 1998;63(1):53-61. (Pubitemid 28060226)
60. Piccirillo G, Cacciafesta M, Viola E, Santagada E, Nocco M, Lionetti M, et al. Influence of aging on cardiac baroreflex sensitivity determined non-invasively by power spectral analysis. Clin Sci (Lond). 2001;100(3):267-74. (Pubitemid 32215997)
61. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, et al. Hyperinsulinemia A link between hypertension obesity and glucose intolerance. J Clin Invest. 1985;75(3):809 -17. doi:10.1172/JCI111776.
62. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, et al. Insulin resistance in essential hypertension. N Engl J Med. 1987;317(6):350-7. doi:10.1056/NEJM198708063170605. (Pubitemid 17118813)
63. Afonso RA, Ribeiro RT, Macedo MP. Defective hepatic nitric oxide action results in HISS-dependent insulin resistance in spontaneously hypertensive rats. Proc West Pharmacol Soc. 2004;47:103-4. (Pubitemid 39564893)
64. Ribeiro RT, Afonso RA, Macedo MP. Hepatic parasympathetic role in insulin resistance on an animal model of hypertension. Metabolism. 2007;56(2):227-33. doi:10.1016/j.metabol.2006.09.018. (Pubitemid 46074070)
65. Swislocki AL, Goodman MN, Khuu DT, Fann KY. Insulin resistance and hypertension: in vivo and in vitro insulin action in skeletal muscle in spontaneously hypertensive and Wistar-Kyoto rats. Am J Hypertens. 1997;10(10 Pt 1):1159-64. (Pubitemid 27488579)
66. Gouveia LM, Kettelhut IC, Foss MC. Abnormalities of glucose metabolism in spontaneously hypertensive rats. Braz J Med Biol Res. 2000;33(11):1357-62.
67. Wu CC, Bohr DF. Role of endothelium in the response to endothelin in hypertension. Hypertension. 1990;16(6):677-81.
68. Chou TC, Yen MH, Li CY, Ding YA. Alterations of nitric oxide synthase expression with aging and hypertension in rats. Hypertension. 1998;31(2):643-8.
69. Bergman RN, Kim SP, Hsu IR, Catalano KJ, Chiu JD, Kabir M, et al. Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk. Am J Med. 2007;120(2 Suppl 1): S3-8. doi:10.1016/j.amjmed. 2006.11.012. discussion S29-32.
70. Large V, Arner P. Regulation of lipolysis in humans. Pathophysiological modulation in obesity, diabetes, and hyperlipidaemia. Diabetes Metab. 1998;24(5):409-18. (Pubitemid 28564954)
71. Lindmark S, Lonn L, Wiklund U, Tufvesson M, Olsson T, Eriksson JW. Dysregulation of the autonomic nervous system can be a link between visceral adiposity and insulin resistance. Obes Res. 2005;13(4):717-28. doi:10.1038/oby.2005.81.
72. Afonso RA, Lautt WW, Schafer J, Legare DJ, Oliveira AG, Macedo MP. High-fat diet results in postprandial insulin resistance that involves parasympathetic dysfunction. Br J Nutr. 2010;104(10): 1450-9. doi:10.1017/S0007114510002400.
73. Koyama K, Chen G, Lee Y, Unger RH. Tissue triglycerides, insulin resistance, and insulin production: implications for hyperinsulinemia of obesity. Am J Physiol. 1997;273(4 Pt 1): E708-13.
74. Korach-Andre M, Gao J, Gounarides JS, Deacon R, Islam A, Laurent D. Relationship between visceral adiposity and intramyocellular lipid content in two rat models of insulin resistance. Am J Physiol Endocrinol Metab. 2005;288(1):E106-16. doi:10.1152/ajpendo.00089.2004. (Pubitemid 40023796)
75. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115(5):1111-9. doi:10.1172/JCI25102. (Pubitemid 40629025)
76. Tilg H, Moschen AR. Inflammatory mechanisms in the regulation of insulin resistance. Mol Med. 2008;14(3-4):222-31. doi:10.2119/2007-00119.Tilg. (Pubitemid 351481853)
77. Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron MJ. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature. 1997;389(6649):374-7. doi:10.1038/38717. (Pubitemid 27415217)
78. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, et al. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature. 2002;415(6869):339-43. doi:10. 1038/415339a 415339a.
79. Afonso RA, Lautt WW, Ribeiro RT, Legare DJ, Macedo MP. Insulin resistance in two animal models of obesity: A comparison of HISS-dependent and HISS-independent insulin action in high-fat diet-fed and Zucker rats. Proc West Pharmacol Soc. 2007;50:110-4.
80. Kim JY, Nolte LA, Hansen PA, Han DH, Kawanaka K, Holloszy JO. Insulin resistance of muscle glucose transport in male and female rats fed a high-sucrose diet. Am J Physiol. 1999;276(3 Pt 2):R665-72. (Pubitemid 29157495)
81. D'Alessandro ME, Chicco A, Karabatas L, Lombardo YB. Role of skeletal muscle on impaired insulin sensitivity in rats fed a sucroserich diet: effect of moderate levels of dietary fish oil. J Nutr Biochem. 2000;11(5):273-80. (Pubitemid 30392413)
82. Pagliassotti MJ, Shahrokhi KA, Moscarello M. Involvement of liver and skeletal muscle in sucrose-induced insulin resistance: dose-response studies. Am J Physiol. 1994;266(5 Pt 2):R1637-44.
83. Chaudhary DP, Boparai RK, Bansal DD. Implications of oxidative stress in high sucrose low magnesium diet fed rats. Eur J Nutr. 2007;46(7):383-90. doi:10.1007/s00394-007-0677-4. (Pubitemid 350276233)
84. Oudot A, Behr-Roussel D, Compagnie S, Caisey S, Le Coz O, Gorny D, et al. Endothelial dysfunction in insulin-resistant rats is associated with oxidative stress and COX pathway dysregulation. Physiol Res. 2009;58(4):499-509.
85. Lautt WW, Schafer J, Macedo MP, Legare DJ. Bethanechol and Nacetylcysteine mimic feeding signals and reverse insulin resistance in fasted and sucrose-induced diabetic rats. Can J Physiol Pharmacol. 2011;89(2):135-42. doi:10.1139/y11-001.
86. Afonso RA, Fernandes AB, Santos C, Ligeiro D, Ribeiro RT, Lima IS, et al. Postprandial insulin resistance in Zucker diabetic fatty rats is associated with parasympathetic-nitric oxide axis deficiencies. J Neuroendocrinol. 2012;24(10):1346-55. doi:10.1111/j.1365-2826.2012.02341.x.
87. Bastyr 3rd EJ, Stuart CA, Brodows RG, Schwartz S, Graf CJ, Zagar A, et al. Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group Diabetes Care. 2000;23(9):1236-41.
88. Marfella R, Quagliaro L, Nappo F, Ceriello A, Giugliano D. Acute hyperglycemia induces an oxidative stress in healthy subjects. J Clin Invest. 2001;108(4):635-6. doi:10.1172/JCI13727. (Pubitemid 32777744)
89. Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care. 2003;26(3):881-5. (Pubitemid 36929359)
90. Monnier L, Colette C, Dunseath GJ, Owens DR. The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes. Diabetes Care. 2007;30(2):263-9. doi:10.2337/dc06-1612. (Pubitemid 46198328)
91. Piconi L, Quagliaro L, Assaloni R, Da Ros R, Maier A, Zuodar G, et al. Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction. Diabetes Metab Res Rev. 2006;22(3):198-203. doi:10.1002/dmrr.613. (Pubitemid 43805400)
92. Woerle HJ, Pimenta WP, Meyer C, Gosmanov NR, Szoke E, Szombathy T, et al. Diagnostic and therapeutic implications of relationships between fasting, 2-hour postchallenge plasma glucose and hemoglobin a1c values. Arch Intern Med. 2004;164(15):1627-32. doi:10.1001/archinte.164.15.1627 164/15/.
93. Zheng F, Lu W, Jia C, Li H, Wang Z, Jia W. Relationships between glucose excursion and the activation of oxidative stress in patients with newly diagnosed type 2 diabetes or impaired glucose regulation. Endocrine. 2010;37(1):201-8. doi:10.1007/s12020-009-9296-6.
94. Hirsch IB, Brownlee M. Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complications. 2005;19(3):178-81. doi:10.1016/j.jdiacomp.2004.10.001. (Pubitemid 40615551)
95. Hirsch IB. Glycemic variability: it's not just about A1C anymore! Diabetes Technol Ther. 2005;7(5):780-3. doi:10.1089/dia.2005.7.780. (Pubitemid 41572082)
96. Risso A, Mercuri F, Quagliaro L, Damante G, Ceriello A. Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am J Physiol Endocrinol Metab. 2001;281(5):E924-30.
97. Owens DR, Wragg KG, Briggs PI, Luzio S, Kimber G, Davies C. Comparison of the metabolic response to a glucose tolerance test and a standardized test meal and the response to serial test meals in normal healthy subjects. Diabetes Care. 1979;2(5):409-13. (Pubitemid 11187197)
98. Ahlkvist L, Vikman J, Pacini G, Ahren B. Synergism by individual macronutrients explains the marked early GLP-1 and islet hormone responses to mixed meal challenge in mice. Regul Pept. 2012;178(1-3):29-35. doi:10.1016/j.regpep.2012.06.004.
99. Patarrao RS, Lautt WW, Afonso RA, Ribeiro RT, Guarino MP, Fernandes AB, et al. Meal-induced insulin sensitization and its parasympathetic regulation in humans. Can J Physiol Pharmacol. 2008;86(12):880-8. doi:10.1139/Y08-080.
100. Sadri P, Reid MA, Afonso RA, Schafer J, Legare DJ, Paula Macedo M, et al. Meal-induced insulin sensitization in conscious and anaesthetized rat models comparing liquid mixed meal with glucose and sucrose. Br J Nutr. 2006;95(2):288-95.
101. Frid AH, Nilsson M, Holst JJ, Bjorck IM. Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects. Am J Clin Nutr. 2005;82(1):69-75. (Pubitemid 41716379)
102. Bernard JR, Liao YH, Hara D, Ding Z, Chen CY, Nelson JL, et al. An amino acid mixture improves glucose tolerance and insulin signaling in Sprague - Dawley rats. Am J Physiol Endocrinol Metab. 2011;300(4):E752-60. doi:10.1152/ajpendo.00643.2010.
103. Kleinert M, Liao YH, Nelson JL, Bernard JR, Wang W, Ivy JL. An amino acid mixture enhances insulin-stimulated glucose uptake in isolated rat epitrochlearis muscle. J Appl Physiol. 2011;111(1):163-9. doi:10.1152/ japplphysiol.01368.2010.
104. Bernard JR, Liao YH, Hara D, Ding Z, Chen CY, Nelson JL, et al. An amino acid mixture improves glucose tolerance and insulin signaling in Sprague - Dawley rats. Am J Physiol Endocrinol Metab. 2012;300(4):E752-60. doi:10.1152/ajpendo.00643.2010.
105. Gunnerud UJ, Heinzle C, Holst JJ, Ostman EM, Bjorck IM. Effects of pre-meal drinks with protein and amino acids on glycemic and metabolic responses at a subsequent composite meal. PLoS One. 2012;7(9):e44731. doi:10.1371/journal.pone.0044731.
106. Blouet C, Mariotti F, Azzout-Marniche D, Mathe V, Mikogami T, Tome D, et al. Dietary cysteine alleviates sucrose-induced oxidative stress and insulin resistance. Free Radic Biol Med. 2007;42(7): 1089-97. doi:10.1016/j. freeradbiomed.2007.01.006. (Pubitemid 46371367)
107. Tateishi N, Higashi T, Naruse A, Nakashima K, Shiozaki H. Rat liver glutathione: possible role as a reservoir of cysteine. J Nutr. 1977;107(1):51-60. (Pubitemid 8030953)
108. Masuda M, Miyasaka K, Funakoshi A. Involvement of 5-hydroxytryptamine (5-HT)3 receptor mechanisms in regulation of basal pancreatic secretion in conscious rats. J Auton Nerv Syst. 1997;62(1-2):58-62. (Pubitemid 27043084)
109. Raybould HE, Glatzle J, Robin C, Meyer JH, Phan T, Wong H, et al. Expression of 5-HT3 receptors by extrinsic duodenal afferents contribute to intestinal inhibition of gastric emptying. Am J Physiol Gastrointest Liver Physiol. 2003;284(3):G367-72. doi:10.1152/ajpgi.00292.2001. (Pubitemid 36227884)
110. Berthoud HR. Vagal and hormonal gut-brain communication: from satiation to satisfaction. Neurogastroenterol Motil. 2008;20 Suppl 1: 64-72. doi:10.1111/j.1365-2982.2008.01104.x.
111. Numao S, Kawano H, Endo N, Yamada Y, Konishi M, Takahashi M, et al. Effects of a single bout of aerobic exercise on short-term low-carbohydrate/ high-fat intake-induced postprandial glucose metabolism during an oral glucose tolerance test. Metabolism. 2013. doi:10.1016/j.metabol.2013.05.005.
112. Pratley RE. The quality of fat in the diet and its impact on insulin sensitivity. Curr Diab Rep. 2002;2(1):69-70.
113. Farrow HA, Rand JS, Morton JM, O'Leary CA, Sunvold GD. Effect of Dietary Carbohydrate, Fat, and Protein on Postprandial Glycemia and Energy Intake in Cats. J Vet Intern Med. 2013. doi:10.1111/jvim.12139.
114. Hishida A, Morita E, Naito M, Okada R, Wakai K, Matsuo K, et al. Associations of apolipoprotein A5 (APOA5), glucokinase (GCK) and glucokinase regulatory protein (GCKR) polymorphisms and lifestyle factors with the risk of dyslipidemia and dysglycemia in Japanese - a cross-sectional data from the J-MICC Study. Endocr J. 2012;59(7):589-99.
115. Gower BA, Goree LL, Chandler-Laney PC, Ellis AC, Casazza K, Granger WM. A higher-carbohydrate, lower-fat diet reduces fasting glucose concentration and improves beta-cell function in individuals with impaired fasting glucose. Metabolism. 2012;61(3):358-65. doi:10.1016/j.metabol.2011.07.011.
116. Stengel A, Goebel-Stengel M, Wang L, Hu E, Karasawa H, Pisegna JR, et al. High-protein diet selectively reduces fat mass and improves glucose tolerance in Western-type diet-induced obese rats. Am J Physiol Regul Integr Comp Physiol. 2013. doi:10.1152/ajpregu.00598.2012.
117. Yach D, Hawkes C, Gould CL, Hofman KJ. The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA. 2004;291(21):2616-22. doi:10.1001/jama.291.21.2616. (Pubitemid 38702780)